Few tools exist to assess replication of chronic pathogens during infection. This has been a considerable barrier to understanding latent tuberculosis, and efforts to develop new therapies generally assume that the bacteria are very slowly replicating or nonreplicating during latency [1] [2] [3] . To monitor Mycobacterium tuberculosis replication within hosts, we exploit an unstable plasmid that is lost at a steady, quantifiable rate from dividing cells in the absence of antibiotic selection. By applying a mathematical model, we calculate bacterial growth and death rates during infection of mice. We show that during chronic infection, the cumulative bacterial burdenenumerating total live, dead and removed organisms encountered by the mouse lung-is substantially higher than estimates from colony-forming units. Our data show that M. tuberculosis replicates throughout the course of chronic infection of mice and is restrained by the host immune system. This approach may also shed light on the replication dynamics of other chronic pathogens.
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Many deadly diseases, such as AIDS, malaria and tuberculosis, result from infections that persist for long periods. Disease processes that unfold over months or years are especially difficult to model in the laboratory. New approaches are sorely needed to generate insight into the pathogenesis and treatment of such agents.
Tuberculosis remains a global scourge, killing two million people per year despite available chemotherapy 4 . The World Health Organization estimates that 1.8 billion people are infected with M. tuberculosis (Mtb) 4 , and the vast majority of cases are clinically latent. Despite decades of research, the physiology of Mtb during persistent infection remains poorly understood. One model of tuberculosis pathogenesis holds that bacilli enter a state of very slow replication or nonreplicating persistence insensitive to host and antibiotic-mediated killing 5, 6 . In Mtb-infected mice, bacterial colony-forming units (CFUs) in the lungs increase and then remain stable over time 7, 8 , suggesting that Mtb does not replicate during the chronic phase. In 1961, this idea was tested by comparing Mtb CFUs with the number of acid-fast bacilli in mice over a long period. The researchers determined that CFUs and total bacteria counts remained similar and stable over time and concluded that ''bacilli remain viable but do not divide,'' a state they termed ''static equilibrium'' 9 . Another group used quantitative real-time PCR to revisit this question, also concluding that Mtb is in static equilibrium 10 . However, some studies suggest there is substantial continued replication in vivo. The immune responses of both Mycobacterium marinum-infected zebrafish and Mtb-infected mice are dynamic throughout chronic infection 8, [11] [12] [13] . Additionally, isoniazid, the firstline agent used to treat latent tuberculosis, has virtually no efficacy against nonreplicating bacilli in vitro [14] [15] [16] or in vivo 17 . Similarly, the rapid reactivation of latent Mtb after anti-tumor necrosis factor-a therapy 18 seems inconsistent with infection by bacteria in a nonreplicating state.
To reassess mycobacterial replication, we developed a method based on pBP10, a circular plasmid carrying a kanamycin resistance marker 19 . Plasmids replicate coordinately with bacterial DNA, sometimes requiring antibiotic selection for their maintenance. Without selection, plasmids are lost from a proportion of daughter cells during cell division, and thus decreasing plasmid numbers can act as a marker of division. We introduced pBP10 into Mycobacterium smegmatis and Mtb to evaluate the feasibility of using this plasmid as a replication clock.
M. smegmatis-pBP10 was maintained in log-phase culture under conditions where doubling times ranged from 2 h to 5 h. Plasmid loss was determined by plating on agar with and without kanamycin. The plasmid was steadily lost as cells divided, with a rate proportional to the growth rate under each condition (Fig. 1a,b) . The plasmid loss per generation was constant, regardless of the replication rate (Fig. 1c) . We applied a mathematical model (Supplementary Methods online) to determine the segregation constant s -the frequency of daughter cells losing plasmid per generation. This value (0.11 ± 0.0074 (s.d.)) was reproducible across all tested growth conditions. Mtb-pBP10 was maintained in log phase for B30 generations by subculturing every 2-3 d without antibiotics under a range of conditions. The Mtb doubling time varied between 18 and 54 h (data not shown). Again, the plasmid loss progressed at a rate proportional to the growth rate (Fig. 1d,e) , and the plasmid loss per generation remained constant despite altered growth rates (Fig. 1f) . The segregation constant s for Mtb was 0.18 ± 0.023.
Mtb-pBP10 cultures were maintained in stationary phase for B20 d without antibiotics, and plasmid loss was reassessed by both CFUs (Fig. 2) and quantitative real-time PCR ( Supplementary Fig. 1 online). The plasmid loss ended after bacterial CFUs stabilized ( Supplementary Fig. 1 ), indicating that Mtb replication, unlike Escherichia coli 20 and M. smegmatis 21 replication, halts in stationary phase. In addition, we measured plasmid loss during anoxia and carbon starvation, conditions putatively linked with nonreplicating persistent Mtb infection in vivo. Under both conditions, CFUs dropped ( Fig. 2a) , but no plasmid loss was detected among the surviving cells (Fig. 2b) . Hence, loss of pBP10 depends on bacterial replication, validating pBP10 as a marker for Mtb division.
To evaluate bacterial replication in vivo, we aerosol-infected C57BL/6 mice with Mtb-pBP10. At various time points, mice were killed, and the percentage of bacteria carrying plasmid in the lungs was measured (Fig. 3a) . Over the initial 4 weeks after infection, bacterial CFUs increased, and plasmid loss was observed (Fig. 3a) . From 4 to 16 weeks, bacterial CFUs remained stable but plasmid loss continued (Fig. 3a) . Because CFUs remained constant, replication must have been balanced by bacterial death, which we quantified with our mathematical model (Supplementary Methods and Table 1) .
We used the Mtb segregation constant determined in vitro and calculated the growth rate r and death rate d for each time interval ( Table 1) . With these parameters, we quantified the total pool of replicating organisms as well as the number removed by death, immune clearance or both to define the cumulative bacterial burden (CBB)-the total number of bacteria live, dead or removed from the mouse lung for the duration of infection ( Table 1) . We then used statistical 'bootstrapping' 22 to construct 95% confidence intervals for each time point (Table 1 and Fig. 3b ). During the first 2 weeks of infection, Mtb growth was rapid (generation time, 21.4 h), similar to that in vitro. The death rate was also substantial, yielding a marked difference between CFUs and CBB (Fig. 3c) . Sixteen weeks after infection, the bacterial replication remained considerable, with a calculated generation time of 4 d ( Table 1) . This growth was balanced by the death rate to yield a plateau in CFUs. After extended infection, at 16 weeks, the CBB in these mice was 1.3 Â 10 7 bacteria, ten times higher than that measured by plating for CFUs ( Table 1) .
We also treated a subset of infected mice with the immunosuppressant dexamethasone for 8 d (80 mg d -1 ). This resulted in a rapid resurgence of Mtb growth ( Table 1 and Fig. 3 ) and the sudden onset of acute TB disease symptoms (lethargy, trembling and weight loss). Simultaneously, plasmid frequency dropped and the CBB jumped from 4.8 Â 10 6 to 1.6 Â 10 7 bacteria ( Table 1 and Fig. 3 ).
Our mathematical model makes certain assumptions about Mtb growth in vitro (Supplementary Methods). To test how these assumptions affected our results in vivo, we modeled alternative assumptions. If, contrary to our assumptions, bacteria die during log phase in vitro, the result would be lower estimates for s and therefore higher estimates for bacterial turnover in vivo (Supplementary Equation 1 online). In addition, if plasmid maintenance were to exert a fitness cost, the model would predict only a very modest reduction in estimated bacterial turnover in vivo (Supplementary Equation 2 online).
This study describes a versatile tool to analyze pathogen dynamics within hosts. With only standard data collection techniques, we measured plasmid loss as a surrogate for Mtb replication. In contrast to current models of chronic tuberculosis that invoke nonreplicating persistence, we observed a decline in plasmid frequency during chronic infection that indicates substantial ongoing bacterial replication. We cannot yet distinguish between the possibility that there is slowed but continuous replication of all bacteria and the possibility that some Mtb divide rapidly amid a dormant subset. Earlier studies using microscopy 9 or PCR 10 concluded that Mtb is nonreplicating or very slowly replicating during chronic mouse infection. However, both experiments assumed that nonviable bacteria, their chromosomes or both are not removed or degraded over time and therefore can be quantified. But if killed organisms are cleared by the host, both techniques would have underestimated the cumulative bacterial burden. Furthermore, data from both are consistent with continued bacterial replication at a reduced rate.
Our results suggest that some aspects of current tuberculosis persistence models should be revisited. Past studies have indicated deteriorating histopathology during chronic mouse tuberculosis infection despite stable CFUs 7, 23 ; such progressive inflammation and tissue damage would be unexpected if the bacilli are dormant but unsurprising if the bacteria still replicate. The current Mtb paradigm 8, 24 argues that robust killing by host defenses begins only with activation of adaptive immunity at around 3 weeks of infection. In contrast, we found substantial Mtb killing within the first 3 weeks of infection (Fig. 3c) , suggesting an early and major role for innate immunity. This is supported by recent work with M. marinum 13 and Mtb 25 infections. Furthermore, the rapid surge in bacterial CFUs in vivo after immunosuppression (Fig. 3a) is consistent with diminished stress on an already dividing population, rather than a reawakening of dormant organisms.
In conclusion, our results challenge the widespread notion that chronic tuberculosis is in static equilibrium, with replication either very slow or nonexistent. Although no animal model perfectly recapitulates human disease, mice provide the only widely used animal model of chronic tuberculosis and have a predictive role in the development of new therapies 26 . Recent studies indicate that granulomas in Mtb-infected mice lack hypoxia [27] [28] [29] , whereas lesions in Mtb-infected guinea pigs, rabbits and primates are hypoxic 29 . The oxygen tension in human tuberculosis granulomas, although unreported, is assumed to be low. We plan to monitor Mtb replication in guinea pigs, rabbits and especially nonhuman primates, as these models offer more relevance to some aspects of human disease. We anticipate that application of this unstable plasmid replication clock may shed light on the in vivo replication dynamics of other persistent agents responsible for widespread human suffering, such as Plasmodium, trypanosomatids and pathogenic fungi. and 50 mg l -1 ferric ammonium citrate. We measured log-phase growth rates at the initiation of growth (high plasmid frequency) and again at the end (low plasmid frequency) to assess the fitness cost of plasmid carriage. We grew hypoxic cultures in 7H9 medium in spinner flasks with 2% oxygen flowthrough as previously described 32 . Before plating, we brought cultures to their original volumes to account for evaporation from the constant air flow. For in vitro stationary phase and starvation experiments with Mtb, we grew rolling cultures for B20 d without subculturing. For the hypoxic experiments, we maintained Mtb in 7H9 medium in 96-well plates placed inside airtight bags with a Gaspak EZ Anaerobe Container System Sachet (Becton Dickinson) and a Gaspak Dry Anaerobic Indicator Strip (Becton Dickinson).
METHODS
Infection of mice. We maintained 6-8-week-old C57BL/6 mice (Jackson Laboratories) in a biosafety level 3 animal facility in accordance with University of Washington Institutional Animal Care and Use Committee protocols. We performed infections in an aerosol infection chamber (Glas-Col) as previously described 7 . At selected time points, we killed groups of five mice by cervical dislocation. We removed the left lung and homogenized it in 2.5 ml PBS with 0.05% Tween-80, and plated serial dilutions on 7H10 ± 30 mg ml -1 kanamycin. We performed the experiment three times with very similar results. We treated five mice at 10 weeks after aerosol infection with dexamethasone sodium phosphate (Spectrum Chemicals and Lab Products) for 8 d (10 mg dexamethasone per 500-ml water bottle, a calculated daily dose of 80 mg d -1 ).
Quantitative real-time PCR. We performed quantitative real-time PCR on a Bio-Rad iCycler and quantified products with iQ SYBR Green Supermix (Bio-Rad) following the manufacturer's instructions. The primers used to quantify pBP10 were 5¢-TCAACGGGAAACGTCTTGCTCG-3¢ and 5¢-ACCT GGAATGCTGTTTTCCCGG-3¢. The primers used to quantify Mtb genomes were 5¢-CTAGTCTGCCCGTATCGCCC-3¢ and 5¢-GAAGGTCCGGGTTCTCTC GG-3¢, hybridizing to the 16s gene. We generated a standard curve with serial dilutions of Mtb genomic DNA of a known concentration. Statistical analyses. Statistical analyses are described in the Supplementary Methods.
Note: Supplementary information is available on the Nature Medicine website.
